TESA/Ipa 13/3

Description

TESAMORELIN + Ipamorelin BLEND 13mg+3mg

supplied in one lyophilized vial for laboratory use only. Strength on the vial is 13 mg / 3 mg. Each order includes a redacted batch Certificate of Analysis. Third-party tested. Research Use Only. Not for human or animal use.

Shipped from Honolulu in insulated packaging with an ice pack.

Synergistic research blend for advanced growth hormone axis studies

Tesa Ipa 13/3 specifications

More Info:

Tesamorelin component

•  Sequence: Trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂ (44-amino-acid GHRH analog with N-terminal modification)

•  Molecular formula: C₂₂₁H₃₆₆N₇₂O₆₇S

•  Molecular weight: ≈ 5135–5136 Da

Ipamorelin component

•  Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂

•  Molecular formula: C₃₈H₄₉N₉O₅

•  Molecular weight: ≈ 711.9 Da

Blend framing: Research combination of the stabilized GHRH analog Tesamorelin with the selective growth hormone secretagogue Ipamorelin. Intended for laboratory studies examining synergistic effects on GH-axis signaling pathways.

For Research Use Only. Not for human consumption.